BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34247041)

  • 1. The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():239-246. PubMed ID: 34247041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study.
    Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
    Int J Gynecol Cancer; 2019 Jan; 29(1):68-76. PubMed ID: 30640686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.
    Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
    Int J Gynecol Cancer; 2019 Mar; 29(3):497-504. PubMed ID: 30833438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure.
    Papathemelis T; Oppermann H; Grafl S; Gerken M; Pauer A; Scharl S; Scharl A; Inwald E; Ignatov A; Ortmann O; Klinkhammer-Schalke M; Hein A; Beckmann MW; Lux MP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):961-969. PubMed ID: 31901975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
    Kikuchi A; Yanase T; Sasagawa M; Honma S
    J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
    Cuccu I; Raspagliesi F; Malzoni M; Vizza E; Papadia A; Di Donato V; Giannini A; De Iaco P; Perrone AM; Plotti F; Angioli R; Casarin J; Ghezzi F; Cianci S; Vizzielli G; Restaino S; Petrillo M; Sorbi F; Multinu F; Schivardi G; De Vitis LA; Falcone F; Lalli L; Berretta R; Mueller MD; Tozzi R; Chiantera V; Benedetti Panici P; Fanfani F; Scambia G; Bogani G
    Eur J Surg Oncol; 2024 Apr; 50(4):108018. PubMed ID: 38428106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy.
    Capozzi VA; Rosati A; Maglietta G; Vargiu V; Scarpelli E; Cosentino F; Sozzi G; Chiantera V; Ghi T; Scambia G; Berretta R; Fanfani F
    Int J Gynecol Cancer; 2023 Jul; 33(7):1013-1020. PubMed ID: 37068852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.